<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00824395</url>
  </required_header>
  <id_info>
    <org_study_id>2005-4675</org_study_id>
    <nct_id>NCT00824395</nct_id>
  </id_info>
  <brief_title>The Genetics of Diabetes in Southern California Chinese Americans</brief_title>
  <official_title>Mitochondria and Metabolic Syndrome in a Southern California Chinese Cohort</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Irvine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Doris Duke Charitable Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, Irvine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research study is to investigate the genetic causes of diabetes.&#xD;
      Specifically, we are interested in the mitochondrial genome and how variants in the&#xD;
      mitochondrial genome influence a person's risk to develop diabetes and metabolic syndrome.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Since our laboratory's initial linkage of Type 2 diabetes to a mtDNA rearrangement in a three&#xD;
      generation maternal pedigree 13 years ago, there has been increasing support for our&#xD;
      hypothesis that mitochondrial dysfunction plays an important role in the etiology of Type 2&#xD;
      Diabetes Mellitus (DM) and the overlapping Metabolic Syndrome (MS). With this study we are&#xD;
      planning an extensive investigation of defects in mitochondrial oxidative phosphorylation&#xD;
      (OXPHOS) caused potentially by deleterious sequence variants in the mitochondrial DNA&#xD;
      (mtDNA). As the primary objective we are trying to further substantiate 2 hypotheses: 1) that&#xD;
      these diabetogenic mtDNA variants, which are proposed to range from recent, relatively&#xD;
      severe, mutations will result in substantial OXPHOS defects with familial DM &amp; MS and 2) that&#xD;
      ancient, relatively mild polymorphisms result in partial OXPHOS defects and an increase in&#xD;
      the risk to develop DM &amp; MS.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Non applicable clinical trial&#xD;
  </why_stopped>
  <start_date>January 2006</start_date>
  <completion_date type="Actual">January 2006</completion_date>
  <primary_completion_date type="Actual">January 2006</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">0</enrollment>
  <condition>Type 1 Diabetes</condition>
  <condition>Type 2 Diabetes</condition>
  <condition>Metabolic Syndrome</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>Individuals with diabetes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>Individuals without diabetes</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      whole blood and serum&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        We are currently recruiting Chinese Americans living in Southern California, espcially in&#xD;
        Orange and Los Angeles Counties. We are particularly in need of Chinese American men and&#xD;
        women with diabetes as well as healthy male controls. We can arrange for offsite weekend&#xD;
        trips to cities within LA or Orange Counties for eligible groups of 10 or more people.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Chinese or Taiwanese ancestry&#xD;
&#xD;
          -  Resident of Southern California&#xD;
&#xD;
          -  Age between 40 and 65&#xD;
&#xD;
          -  Both people with and without diabetes are welcome to enroll.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Younger than 40 years or older than 65 years&#xD;
&#xD;
          -  Ancestry is not Chinese or Taiwanese&#xD;
&#xD;
          -  Not a resident of Southern California&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Douglas C Wallace, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UC Irvine Center for Mitochondrial Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UC Irvine General Clinical Research Center</name>
      <address>
        <city>Irvine</city>
        <state>California</state>
        <zip>92697</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 15, 2009</study_first_submitted>
  <study_first_submitted_qc>January 15, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 16, 2009</study_first_posted>
  <last_update_submitted>January 22, 2021</last_update_submitted>
  <last_update_submitted_qc>January 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>diabetes</keyword>
  <keyword>type 1</keyword>
  <keyword>type 2</keyword>
  <keyword>metabolic syndrome</keyword>
  <keyword>mitochondria</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Metabolic Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

